VESPRO: An Individual Patient Data Prospective Meta-Analysis of Selective Internal Radiation Therapy Versus Sorafenib for Advanced, Locally Advanced, or Recurrent Hepatocellular Carcinoma of the SARAH and SIRveNIB Trials

BACKGROUND: Untreated advanced hepatocellular carcinoma (HCC) has an overall poor prognosis. Currently there are 2 ongoing prospective randomized controlled trials that are evaluating the efficacy and safety of sorafenib and selective internal radiation therapy (SIRT) with yttrium-90 resin microsphe...

Descripción completa

Detalles Bibliográficos
Autores principales: Gebski, Val, Gibbs, Emma, Gandhi, Mihir, Chatellier, Gilles, Dinut, Aurelia, Pereira, Helena, Chow, Pierce KH, Vilgrain, Valérie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2017
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5332836/
https://www.ncbi.nlm.nih.gov/pubmed/28202430
http://dx.doi.org/10.2196/resprot.7016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5332836/
https://www.ncbi.nlm.nih.gov/pubmed/28202430
http://dx.doi.org/10.2196/resprot.7016

Ejemplares similares